NCT05218811Recruiting

Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach

Cryotherapy and Robotic Assisted Non Ischemic Nephron Sparring Surgery

Source: ClinicalTrials.gov · Last updated 26 Jan 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Patients with renal masses eligible to partial nephrectomy often require arterial ischemia to control or prevent blood loss during this surgical procedure. This study aims to determine the safety and efficacy of renal cryoablation at the tumor bed, as a substitute measure or technique vs total or selective arterial renal ischemia.

Status (registry): Recruiting
Study type: Interventional
Enrollment: 150 (estimated)
First submitted: 26 Sept 2021
Start date: 15 May 2020
Primary completion date: 15 May 2026
Lead sponsor: Urological Research Network, LLC
Diseases: Kidney cancer
NCT number: NCT05218811

What you commit to

Study type: Interventional
Planned participants: 150
From 15 May 2020 to the primary completion date, 15 May 2026
1 site in 1 country
Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

Prior renal surgery

Other illness

M1 Disease

Who the study is looking for

Patients with ages between 45-90-year-old.
Renal tumor ≤ 7 cm in the greatest extension, \>50% exophitic.

Age in the registry: 55 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

Site	City	Country	Site status
Urological Research Network Coordinator of this site? Confirm its status	Miami Lakes	United States	Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.